60 Degrees Pharmaceuticals SXTP
NASDAQ SXTP
$1.25 -0.08 (-6.02%)
At close: Oct 1, 2026 · 4:00 PM EDT

60 Degrees Pharmaceuticals (SXTP) Accumulated Expenses (2023)

Updated

60 Degrees Pharmaceuticals' Accumulated Expenses was $75,000 in Q4 2023.

Analysis

60 Degrees Pharmaceuticals (SXTP) Accumulated Expenses (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 60 Degrees Pharmaceuticals 3.54 Mn 2.43 Mn 56,798.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 75,000.00
Mar 31, 2023 75,000.00
API Access

60 Degrees Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=SXTP&period=max&api_key=YOUR_API_KEY